Salesforce (CRM) Stock Gains Wall Street Support as Analysts See 55% Upside Potential

Key Takeaways

• CRM shares opened Friday at $165.94, reflecting a ~41% decline year-to-date and a ~58% drop from the late-2024 high
• Guggenheim shifted its stance from Neutral to Buy, establishing a $228 target and arguing valuations reflect an “Armageddon” baseline
• Analyst consensus averages Moderate Buy, with a mean target near $254 — suggesting potential gains of 55%–57%
• Q1 results topped forecasts: EPS reached $3.88 against $3.13 estimates, while revenue hit $11.13B, climbing 13.3% year-over-year
• The company’s AI portfolio — spanning Agentforce and Slack-integrated agents — now drives more than $2.3B in ARR

Shares of Salesforce (CRM) began Friday trading at $165.94, marking a steep year-to-date decline of approximately 41% and a roughly 58% retreat from the late-2024 high around $276.80. The downturn stems primarily from investor anxiety that AI-powered agents might render conventional CRM platforms redundant.

Salesforce, Inc., CRM

Yet a growing number of Wall Street voices believe the market has overreacted.

This week, Guggenheim analyst John DiFucci elevated CRM from Neutral to Buy, establishing a $228 price objective. His rationale: trading at approximately 3.7x recurring revenue and 11x EV/NTM free cash flow, the valuation assumes perpetual 5% business contraction — a scenario he deems implausible.

Citigroup likewise moved Salesforce to Buy this week, joining a widening group of analysts convinced the correction has exceeded rational bounds.

Current Street consensus shows Moderate Buy, with 28 Buy ratings, 6 Hold recommendations, and 4 Sell calls.

The mean price objective hovers around $254, pointing to approximately 55%–57% potential appreciation from present levels. Citizens JMP maintains the Street’s highest conviction with a $315 target.

Strong Q1 Results and Forward Outlook

Salesforce delivered Q1 figures on May 27th that surpassed Wall Street projections. Earnings per share landed at $3.88, topping the $3.13 consensus by $0.75. Revenue totaled $11.13 billion, representing 13.3% year-over-year growth and edging past the $11.05 billion forecast.

For fiscal 2027, management projects full-year EPS in the $14.060–$14.120 range. Second-quarter fiscal 2027 guidance calls for EPS between $3.250 and $3.270.

The stock trades within a 52-week range of $146.32 to $276.80. The 50-day moving average currently stands at $173.23, while the 200-day moving average registers at $197.71.

AI Product Suite Driving Material Revenue

Despite apprehension surrounding AI-driven disruption, Salesforce’s proprietary AI offerings are already delivering substantial financial contributions. The product lineup — encompassing Agentforce, Data 360, Slack-integrated AI agents, and Headless 360 APIs — currently generates north of $2.3 billion in rapidly expanding annual recurring revenue.

This metric serves as a focal point for analysts arguing the enterprise isn’t merely protecting existing market share — it’s actively capturing emerging opportunities.

On the institutional front, Kepler Cheuvreux Suisse SA expanded its CRM position by 284.1% during Q1, acquiring an additional 12,568 shares to reach a total stake of 16,992 shares valued around $3.17 million.

Vanguard Group maintains 89.8 million shares worth approximately $23.8 billion. State Street controls 50 million shares, with institutional investors collectively representing 80.43% of outstanding equity.

Salesforce distributed a $0.44 quarterly dividend per share on July 2nd, equating to a $1.76 annualized payout and yielding roughly 1.1%.

The board greenlit a $25 billion buyback authorization in March, permitting repurchases of up to 14.1% of outstanding shares via open market transactions.

HC Wainwright took a contrarian stance, lowering CRM to Negative on June 18th — representing one of just four Sell-rated opinions currently assigned to the stock.

The post Salesforce (CRM) Stock Gains Wall Street Support as Analysts See 55% Upside Potential appeared first on Blockonomi.